Repligen Corporation Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Waltham MA United States (1981)

Organization Overview

First Clinical Trial
2002
NCT00036231
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree